Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

OncoMX: A Knowledgebase for Exploring Cancer Biomarkers in the Context of Related Cancer and Healthy Data.

Dingerdissen HM, Bastian F, Vijay-Shanker K, Robinson-Rechavi M, Bell A, Gogate N, Gupta S, Holmes E, Kahsay R, Keeney J, Kincaid H, King CH, Liu D, Crichton DJ, Mazumder R.

JCO Clin Cancer Inform. 2020 Mar;4:210-220. doi: 10.1200/CCI.19.00117.

2.

Schistosomiasis-associated pulmonary arterial hypertension: a systematic review.

Knafl D, Gerges C, King CH, Humbert M, Bustinduy AL.

Eur Respir Rev. 2020 Feb 5;29(155). pii: 190089. doi: 10.1183/16000617.0089-2019. Print 2020 Mar 31. Review.

3.

Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel.

Walker JW, Kittur N, Binder S, Castleman JD, Drake JM, Campbell CH, King CH, Colley DG.

Am J Trop Med Hyg. 2020 Feb;102(2):328-338. doi: 10.4269/ajtmh.19-0658.

4.

Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?

Toor J, Rollinson D, Turner HC, Gouvras A, King CH, Medley GF, Hollingsworth TD, Anderson RM.

J Infect Dis. 2019 Dec 12. pii: jiz609. doi: 10.1093/infdis/jiz609. [Epub ahead of print]

PMID:
31829414
5.

Modeling Approaches to Predicting Persistent Hotspots in SCORE Studies for Gaining Control of Schistosomiasis Mansoni in Kenya and Tanzania.

Shen Y, Sung MH, King CH, Binder S, Kittur N, Whalen CC, Colley DG.

J Infect Dis. 2020 Feb 18;221(5):796-803. doi: 10.1093/infdis/jiz529.

6.

Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.

Gu S, Zaidi S, Hassan MI, Mohammad T, Malta TM, Noushmehr H, Nguyen B, Crandall KA, Srivastav J, Obias V, Lin P, Nguyen BN, Yao M, Yao R, King CH, Mazumder R, Mishra B, Rao S, Mishra L.

Gastroenterology. 2020 Jan;158(1):238-252. doi: 10.1053/j.gastro.2019.09.023. Epub 2019 Oct 1.

PMID:
31585122
7.

Improving public health control of schistosomiasis with a modified WHO strategy: a model-based comparison study.

Li EY, Gurarie D, Lo NC, Zhu X, King CH.

Lancet Glob Health. 2019 Oct;7(10):e1414-e1422. doi: 10.1016/S2214-109X(19)30346-8.

8.

Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmission.

Toor J, Truscott JE, Werkman M, Turner HC, Phillips AE, King CH, Medley GF, Anderson RM.

Parasit Vectors. 2019 Sep 16;12(1):437. doi: 10.1186/s13071-019-3611-8.

9.

Baseline human gut microbiota profile in healthy people and standard reporting template.

King CH, Desai H, Sylvetsky AC, LoTempio J, Ayanyan S, Carrie J, Crandall KA, Fochtman BC, Gasparyan L, Gulzar N, Howell P, Issa N, Krampis K, Mishra L, Morizono H, Pisegna JR, Rao S, Ren Y, Simonyan V, Smith K, VedBrat S, Yao MD, Mazumder R.

PLoS One. 2019 Sep 11;14(9):e0206484. doi: 10.1371/journal.pone.0206484. eCollection 2019.

10.

Five-Year Impact of Different Multi-Year Mass Drug Administration Strategies on Childhood Schistosoma mansoni-Associated Morbidity: A Combined Analysis from the Schistosomiasis Consortium for Operational Research and Evaluation Cohort Studies in the Lake Victoria Regions of Kenya and Tanzania.

Shen Y, Wiegand RE, Olsen A, King CH, Kittur N, Binder S, Zhang F, Whalen CC, Secor WE, Montgomery SP, Mwinzi PNM, Magnussen P, Kinung'hi S, Campbell CH, Colley DG.

Am J Trop Med Hyg. 2019 Dec;101(6):1336-1344. doi: 10.4269/ajtmh.19-0273.

11.

Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel.

Kittur N, King CH, Campbell CH, Kinung'hi S, Mwinzi PNM, Karanja DMS, N'Goran EK, Phillips AE, Gazzinelli-Guimaraes PH, Olsen A, Magnussen P, Secor WE, Montgomery SP, Utzinger J, Walker JW, Binder S, Colley DG.

Am J Trop Med Hyg. 2019 Sep;101(3):617-627. doi: 10.4269/ajtmh.19-0193.

12.

Corrections to: Molluscicidal effectiveness of Luo-Wei, a novel plant-derived molluscicide, against Oncomelania hupensis, Biomphalaria alexandrina and Bulinus truncatus.

Jia TW, Wang W, Sun LP, Lv S, Yang K, Zhang NM, Huang XB, Liu JB, Liu HC, Liu RH, Gawish FA, Habib MR, El-Emam MA, King CH, Zhou XN.

Infect Dis Poverty. 2019 Jun 6;8(1):42. doi: 10.1186/s40249-019-0548-2.

13.

Early Childhood Anemia in a Birth Cohort in Coastal Kenya: Links to Infection and Nutrition.

Kao J, Mutuku F, Martin S, Lee J, Mwandi J, Mukoko D, Malhotra I, King CH, LaBeaud AD.

Am J Trop Med Hyg. 2019 Jul;101(1):242-252. doi: 10.4269/ajtmh.17-0688.

14.

Molluscicidal effectiveness of Luo-Wei, a novel plant-derived molluscicide, against Oncomelania hupensis, Biomphalaria alexandrina and Bulinus truncatus.

Jia TW, Wang W, Sun LP, Lv S, Yang K, Zhang NM, Huang XB, Liu JB, Liu HC, Liu RH, Gawish FA, Habib MR, El-Emam MA, King CH, Zhou XN.

Infect Dis Poverty. 2019 Mar 31;8(1):27. doi: 10.1186/s40249-019-0535-7. Erratum in: Infect Dis Poverty. 2019 Jun 6;8(1):42.

15.

The influence of raw milk exposures on Rift Valley fever virus transmission.

Grossi-Soyster EN, Lee J, King CH, LaBeaud AD.

PLoS Negl Trop Dis. 2019 Mar 20;13(3):e0007258. doi: 10.1371/journal.pntd.0007258. eCollection 2019 Mar.

16.

Helminthiasis Epidemiology and Control: Scoring Successes and Meeting the Remaining Challenges.

King CH.

Adv Parasitol. 2019;103:11-30. doi: 10.1016/bs.apar.2018.08.001. Epub 2018 Aug 31. Review.

PMID:
30878055
17.

Parasitic infections during pregnancy need not affect infant antibody responses to early vaccination against Streptococcus pneumoniae, diphtheria, or Haemophilus influenzae type B.

McKittrick ND, Malhotra IJ, Vu DM, Boothroyd DB, Lee J, Krystosik AR, Mutuku FM, King CH, LaBeaud AD.

PLoS Negl Trop Dis. 2019 Feb 28;13(2):e0007172. doi: 10.1371/journal.pntd.0007172. eCollection 2019 Feb.

18.

Enabling precision medicine via standard communication of HTS provenance, analysis, and results.

Alterovitz G, Dean D, Goble C, Crusoe MR, Soiland-Reyes S, Bell A, Hayes A, Suresh A, Purkayastha A, King CH, Taylor D, Johanson E, Thompson EE, Donaldson E, Morizono H, Tsang H, Vora JK, Goecks J, Yao J, Almeida JS, Keeney J, Addepalli K, Krampis K, Smith KM, Guo L, Walderhaug M, Schito M, Ezewudo M, Guimera N, Walsh P, Kahsay R, Gottipati S, Rodwell TC, Bloom T, Lai Y, Simonyan V, Mazumder R.

PLoS Biol. 2018 Dec 31;16(12):e3000099. doi: 10.1371/journal.pbio.3000099. eCollection 2018 Dec.

19.

Acute Flavivirus and Alphavirus Infections among Children in Two Different Areas of Kenya, 2015.

Hortion J, Mutuku FM, Eyherabide AL, Vu DM, Boothroyd DB, Grossi-Soyster EN, King CH, Ndenga BA, LaBeaud AD.

Am J Trop Med Hyg. 2019 Jan;100(1):170-173. doi: 10.4269/ajtmh.18-0297.

20.

Accuracy of the WHO praziquantel dose pole for large-scale community treatment of urogenital schistosomiasis in northern Mozambique: Is it time for an update?

Gazzinelli-Guimaraes PH, Dhanani N, King CH, Campbell CH, Aurelio HO, Ferro J, Nala R, Fenwick A, Phillips AE.

PLoS Negl Trop Dis. 2018 Nov 15;12(11):e0006957. doi: 10.1371/journal.pntd.0006957. eCollection 2018 Nov.

21.

The design of schistosomiasis monitoring and evaluation programmes: The importance of collecting adult data to inform treatment strategies for Schistosoma mansoni.

Toor J, Turner HC, Truscott JE, Werkman M, Phillips AE, Alsallaq R, Medley GF, King CH, Anderson RM.

PLoS Negl Trop Dis. 2018 Oct 8;12(10):e0006717. doi: 10.1371/journal.pntd.0006717. eCollection 2018 Oct.

22.

Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control.

French MD, Evans D, Fleming FM, Secor WE, Biritwum NK, Brooker SJ, Bustinduy A, Gouvras A, Kabatereine N, King CH, Rebollo Polo M, Reinhard-Rupp J, Rollinson D, Tchuem Tchuenté LA, Utzinger J, Waltz J, Zhang Y.

PLoS Negl Trop Dis. 2018 Jun 28;12(6):e0006484. doi: 10.1371/journal.pntd.0006484. eCollection 2018 Jun. No abstract available.

23.

Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?

Toor J, Alsallaq R, Truscott JE, Turner HC, Werkman M, Gurarie D, King CH, Anderson RM.

Clin Infect Dis. 2018 Jun 1;66(suppl_4):S245-S252. doi: 10.1093/cid/ciy001.

24.

The human-snail transmission environment shapes long term schistosomiasis control outcomes: Implications for improving the accuracy of predictive modeling.

Gurarie D, Lo NC, Ndeffo-Mbah ML, Durham DP, King CH.

PLoS Negl Trop Dis. 2018 May 21;12(5):e0006514. doi: 10.1371/journal.pntd.0006514. eCollection 2018 May.

25.

Nasopharyngeal Carriage of Streptococcus pneumoniae in Children in Coastal Kenya.

Heath CJ, Nayakwadi-Singer M, King CH, Malhotra I, Mutuku F, Mukoko D, LaBeaud AD.

Am J Trop Med Hyg. 2018 Apr;98(4):1046-1050. doi: 10.4269/ajtmh.16-0813. Epub 2018 Feb 22.

26.

Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi.

Clements MN, Corstjens PLAM, Binder S, Campbell CH Jr, de Dood CJ, Fenwick A, Harrison W, Kayugi D, King CH, Kornelis D, Ndayishimiye O, Ortu G, Lamine MS, Zivieri A, Colley DG, van Dam GJ.

Parasit Vectors. 2018 Feb 23;11(1):111. doi: 10.1186/s13071-018-2700-4.

27.

Underestimation of the global burden of schistosomiasis.

King CH, Galvani AP.

Lancet. 2018 Jan 27;391(10118):307-308. doi: 10.1016/S0140-6736(18)30098-9. Epub 2018 Jan 31. No abstract available.

PMID:
29413041
28.

Mapping Out the under-Recognized Burden of Human Infertility Linked to Schistosoma haematobium Infection.

King CH.

Am J Trop Med Hyg. 2018 Apr;98(4):937-938. doi: 10.4269/ajtmh.17-1016. Epub 2018 Feb 1. No abstract available.

29.

Cord Blood Antiparasite Interleukin 10 as a Risk Marker for Compromised Vaccine Immunogenicity in Early Childhood.

Malhotra I, LaBeaud AD, Morris N, McKibben M, Mungai P, Muchiri E, King CL, King CH.

J Infect Dis. 2018 Apr 11;217(9):1426-1434. doi: 10.1093/infdis/jiy047.

30.

Historical perspective: Revisiting the St. Lucia Project, a multi-year comparison trial of schistosomiasis control strategies.

Ivy JA, King CH, Cook JA, Colley DG.

PLoS Negl Trop Dis. 2018 Jan 31;12(1):e0006223. doi: 10.1371/journal.pntd.0006223. eCollection 2018 Jan. No abstract available.

31.

Cognitive deficits and educational loss in children with schistosome infection-A systematic review and meta-analysis.

Ezeamama AE, Bustinduy AL, Nkwata AK, Martinez L, Pabalan N, Boivin MJ, King CH.

PLoS Negl Trop Dis. 2018 Jan 12;12(1):e0005524. doi: 10.1371/journal.pntd.0005524. eCollection 2018 Jan. Review.

32.

Impact and cost-effectiveness of snail control to achieve disease control targets for schistosomiasis.

Lo NC, Gurarie D, Yoon N, Coulibaly JT, Bendavid E, Andrews JR, King CH.

Proc Natl Acad Sci U S A. 2018 Jan 23;115(4):E584-E591. doi: 10.1073/pnas.1708729114. Epub 2018 Jan 4.

33.

Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.

Phillips AE, Gazzinelli-Guimaraes PH, Aurelio HO, Ferro J, Nala R, Clements M, King CH, Fenwick A, Fleming FM, Dhanani N.

PLoS Negl Trop Dis. 2017 Dec 8;11(12):e0006061. doi: 10.1371/journal.pntd.0006061. eCollection 2017 Dec.

34.

Cross-sectional interview study of fertility, pregnancy, and urogenital schistosomiasis in coastal Kenya: Documented treatment in childhood is associated with reduced odds of subfertility among adult women.

Miller-Fellows SC, Howard L, Kramer R, Hildebrand V, Furin J, Mutuku FM, Mukoko D, Ivy JA, King CH.

PLoS Negl Trop Dis. 2017 Nov 27;11(11):e0006101. doi: 10.1371/journal.pntd.0006101. eCollection 2017 Nov.

35.

Systematic review of community-based, school-based, and combined delivery modes for reaching school-aged children in mass drug administration programs for schistosomiasis.

Burnim M, Ivy JA, King CH.

PLoS Negl Trop Dis. 2017 Oct 27;11(10):e0006043. doi: 10.1371/journal.pntd.0006043. eCollection 2017 Oct. Review.

36.

Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis.

Kittur N, Binder S, Campbell CH, King CH, Kinung'hi S, Olsen A, Magnussen P, Colley DG.

Am J Trop Med Hyg. 2017 Dec;97(6):1810-1817. doi: 10.4269/ajtmh.17-0368. Epub 2017 Sep 21.

37.

Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.

Shen Y, King CH, Binder S, Zhang F, Whalen CC, Evan Secor W, Montgomery SP, Mwinzi PNM, Olsen A, Magnussen P, Kinung'hi S, Phillips AE, Nalá R, Ferro J, Aurelio HO, Fleming F, Garba A, Hamidou A, Fenwick A, Campbell CH Jr, Colley DG.

BMC Infect Dis. 2017 Sep 29;17(1):652. doi: 10.1186/s12879-017-2738-5.

38.

The global burden of disease study 2013: What does it mean for the NTDs?

Herricks JR, Hotez PJ, Wanga V, Coffeng LE, Haagsma JA, Basáñez MG, Buckle G, Budke CM, Carabin H, Fèvre EM, Fürst T, Halasa YA, King CH, Murdoch ME, Ramaiah KD, Shepard DS, Stolk WA, Undurraga EA, Stanaway JD, Naghavi M, Murray CJL.

PLoS Negl Trop Dis. 2017 Aug 3;11(8):e0005424. doi: 10.1371/journal.pntd.0005424. eCollection 2017 Aug. No abstract available.

39.

The substructure of three repetitive DNA regions of Schistosoma haematobium group species as a potential marker for species recognition and interbreeding detection.

Abbasi I, Webster BL, King CH, Rollinson D, Hamburger J.

Parasit Vectors. 2017 Aug 1;10(1):364. doi: 10.1186/s13071-017-2281-7.

40.

Change in children's school behavior after mass administration of praziquantel for Schistosoma mansoni infection in endemic areas of western Kenya: A pilot study using the Behavioral Assessment System for Children (BASC-2).

Musuva R, Shen Y, Wei X, Binder S, Ivy JA, Secor WE, Montgomery SP, King CH, Mwinzi PNM.

PLoS One. 2017 Jul 26;12(7):e0181975. doi: 10.1371/journal.pone.0181975. eCollection 2017.

41.

Rift Valley Fever Seroprevalence in Coastal Kenya.

Grossi-Soyster EN, Banda T, Teng CY, Muchiri EM, Mungai PL, Mutuku FM, Gildengorin G, Kitron U, King CH, Desiree Labeaud A.

Am J Trop Med Hyg. 2017 Jul;97(1):115-120. doi: 10.4269/ajtmh.17-0104.

42.

Pharmacologic Properties of Novel Local Anesthetic Agents in Anesthesia Practice.

King CH, Beutler SS, Kaye AD, Urman RD.

Anesthesiol Clin. 2017 Jun;35(2):315-325. doi: 10.1016/j.anclin.2017.01.019. Epub 2017 Apr 14. Review.

PMID:
28526152
43.

The evolving schistosomiasis agenda 2007-2017-Why we are moving beyond morbidity control toward elimination of transmission.

King CH.

PLoS Negl Trop Dis. 2017 Apr 20;11(4):e0005517. doi: 10.1371/journal.pntd.0005517. eCollection 2017 Apr. No abstract available.

44.

Parasitic Infections in Pregnancy Decrease Placental Transfer of Antipneumococcus Antibodies.

McKittrick ND, Vu DM, Malhotra I, King CH, Mutuku F, LaBeaud AD.

Clin Vaccine Immunol. 2017 Jun 5;24(6). pii: e00039-17. doi: 10.1128/CVI.00039-17. Print 2017 Jun.

45.

Pneumococcal Vaccine Response After Exposure to Parasites in Utero, in Infancy, or Mid-Childhood.

Nayakwadi Singer M, Heath C, Muinde J, Gildengorin V, Mutuku FM, Vu D, Mukoko D, King CL, Malhotra IJ, King CH, LaBeaud AD.

Pediatrics. 2017 Apr;139(4). pii: e20162781. doi: 10.1542/peds.2016-2781. Epub 2017 Mar 16.

46.

A comparison of two mathematical models of the impact of mass drug administration on the transmission and control of schistosomiasis.

Truscott JE, Gurarie D, Alsallaq R, Toor J, Yoon N, Farrell SH, Turner HC, Phillips AE, Aurelio HO, Ferro J, King CH, Anderson RM.

Epidemics. 2017 Mar;18:29-37. doi: 10.1016/j.epidem.2017.02.003.

47.

One hundred years of neglect in paediatric schistosomiasis.

Bustinduy AL, Wright S, Joekes EC, Kabatereine NB, Reinhard-Rupp J, King CH, Stothard JR.

Parasitology. 2017 Oct;144(12):1613-1623. doi: 10.1017/S0031182017000014. Epub 2017 Mar 1. Review.

48.

Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis.

Andrade G, Bertsch DJ, Gazzinelli A, King CH.

PLoS Negl Trop Dis. 2017 Feb 17;11(2):e0005372. doi: 10.1371/journal.pntd.0005372. eCollection 2017 Feb. Review.

49.

Countrywide Reassessment of Schistosoma mansoni Infection in Burundi Using a Urine-Circulating Cathodic Antigen Rapid Test: Informing the National Control Program.

Ortu G, Ndayishimiye O, Clements M, Kayugi D, Campbell CH, Lamine MS, Zivieri A, Magalhaes RS, Binder S, King CH, Fenwick A, Colley DG, Jourdan PM.

Am J Trop Med Hyg. 2017 Mar;96(3):664-673. doi: 10.4269/ajtmh.16-0671. Epub 2017 Apr 6.

50.

Divergent Effects of Schistosoma haematobium Exposure on Intermediate-Host Snail Species Bulinus nasutus and Bulinus globosus from Coastal Kenya.

Kariuki HC, Ivy JA, Muchiri EM, Sutherland LJ, King CH.

Am J Trop Med Hyg. 2017 Apr;96(4):850-855. doi: 10.4269/ajtmh.16-0614. Epub 2017 Jan 23.

Supplemental Content

Support Center